Dr Reddy’s Lab launches Treprostinil Injection in the U.S.

Will be supplied as 20 mg/20 mL, 50 mg/20 mL, 100 mg/20 mL or 200 mg/20 mL vials

Dr Reddy’s Laboratories has announced the launch of Treprostinil Injection in the U.S. market.

It is a therapeutic equivalent generic version of Remodulin (treprostinil) Injection, approved by U. S. Food and Drug Administration (USFDA).

Dr Reddy’s Treprostinil Injection is supplied as 20 mg/20 mL, 50 mg/20 mL, 100 mg/20 mL or 200 mg/20 mL vials.